THE ASTRAZENECA vaccine has been mired in controversy over reports of a rare blood clotting side effect, despite occurrences being vanishingly rare. Now the European Medicines Agency's - the European drug regulator - has added a rare new side effect to its production description for the AstraZeneca COVID-19 vaccine.